{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:23:01Z","timestamp":1791332581232,"version":"4.3.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T00:00:00Z","timestamp":1251849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00125-009-1502-9","type":"journal-article","created":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T10:57:35Z","timestamp":1251802655000},"page":"27-35","source":"Crossref","is-referenced-by-count":150,"title":["Efficacy of leptin therapy in the different forms of human lipodystrophy"],"prefix":"10.1007","volume":"53","author":[{"given":"A. Y.","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. C.","family":"Lupsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. K.","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gorden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,2]]},"reference":[{"key":"1502_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","volume":"105","author":"O Gavrilova","year":"2000","unstructured":"Gavrilova O, Marcus-Samuels B, Graham D et al (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105:271\u2013278","journal-title":"J Clin Invest"},{"key":"1502_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","volume":"401","author":"I Shimomura","year":"1999","unstructured":"Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL (1999) Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401:73\u201376","journal-title":"Nature"},{"key":"1502_CR3","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2337\/diabetes.50.6.1440","volume":"50","author":"K Ebihara","year":"2001","unstructured":"Ebihara K, Ogawa Y, Masuzaki H et al (2001) Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 50:1440\u20131448","journal-title":"Diabetes"},{"key":"1502_CR4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","volume":"346","author":"EA Oral","year":"2002","unstructured":"Oral EA, Simha V, Ruiz E et al (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570\u2013578","journal-title":"N Engl J Med"},{"key":"1502_CR5","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1542\/peds.2006-3165","volume":"120","author":"J Beltrand","year":"2007","unstructured":"Beltrand J, Beregszaszi M, Chevenne D et al (2007) Metabolic correction induced by leptin replacement treatment in young children with Berardinelli\u2013Seip congenital lipoatrophy. Pediatrics 120:e291\u2013e296","journal-title":"Pediatrics"},{"key":"1502_CR6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","volume":"92","author":"K Ebihara","year":"2007","unstructured":"Ebihara K, Kusakabe T, Hirata M et al (2007) Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab 92:532\u2013541","journal-title":"J Clin Endocrinol Metab"},{"key":"1502_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2265.2007.03095.x","volume":"68","author":"JM Guettier","year":"2008","unstructured":"Guettier JM, Park JY, Cochran EK et al (2008) Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation. Clin Endocrinol (Oxf) 68:547\u2013554","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1502_CR8","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","volume":"54","author":"ED Javor","year":"2005","unstructured":"Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P (2005) Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 54:1994\u20132002","journal-title":"Diabetes"},{"key":"1502_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jc.2007-1856","volume":"93","author":"JY Park","year":"2008","unstructured":"Park JY, Chong AY, Cochran EK et al (2008) Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. J Clin Endocrinol Metab 93:26\u201331","journal-title":"J Clin Endocrinol Metab"},{"key":"1502_CR10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.metabol.2006.11.010","volume":"56","author":"JY Park","year":"2007","unstructured":"Park JY, Javor ED, Cochran EK, DePaoli AM, Gorden P (2007) Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metabolism 56:508\u2013516","journal-title":"Metabolism"},{"key":"1502_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.metabol.2003.10.019","volume":"53","author":"SA Moran","year":"2004","unstructured":"Moran SA, Patten N, Young JR et al (2004) Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy. Metabolism 53:513\u2013519","journal-title":"Metabolism"},{"key":"1502_CR12","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1210\/jc.2003-032140","volume":"89","author":"ED Javor","year":"2004","unstructured":"Javor ED, Moran SA, Young JR et al (2004) Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy. J Clin Endocrinol Metab 89:3199\u20133207","journal-title":"J Clin Endocrinol Metab"},{"key":"1502_CR13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2215\/CJN.01271005","volume":"1","author":"C Musso","year":"2006","unstructured":"Musso C, Javor E, Cochran E, Balow JE, Gorden P (2006) Spectrum of renal diseases associated with extreme forms of insulin resistance. Clin J Am Soc Nephrol 1:616\u2013622","journal-title":"Clin J Am Soc Nephrol"},{"key":"1502_CR14","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1365-4632.2006.02888.x","volume":"45","author":"JA Yiannias","year":"2006","unstructured":"Yiannias JA, DiCaudo DJ, Maskin E (2006) Peripheral T cell lymphoma presenting as lipoatrophy and nodules. Int J Dermatol 45:1415\u20131419","journal-title":"Int J Dermatol"},{"key":"1502_CR15","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","volume":"282","author":"SB Heymsfield","year":"1999","unstructured":"Heymsfield SB, Greenberg AS, Fujioka K et al (1999) Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282:1568\u20131575","journal-title":"JAMA"},{"key":"1502_CR16","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1210\/jc.2003-031868","volume":"89","author":"JR McDuffie","year":"2004","unstructured":"McDuffie JR, Riggs PA, Calis KA et al (2004) Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency. J Clin Endocrinol Metab 89:4258\u20134263","journal-title":"J Clin Endocrinol Metab"},{"key":"1502_CR17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","volume":"109","author":"KF Petersen","year":"2002","unstructured":"Petersen KF, Oral EA, Dufour S et al (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345\u20131350","journal-title":"J Clin Invest"},{"key":"1502_CR18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diacare.26.1.30","volume":"26","author":"V Simha","year":"2003","unstructured":"Simha V, Szczepaniak LS, Wagner AJ, DePaoli AM, Garg A (2003) Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care 26:30\u201335","journal-title":"Diabetes Care"},{"key":"1502_CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/rp.59.1.305","volume":"59","author":"C Bjorbaek","year":"2004","unstructured":"Bjorbaek C, Kahn BB (2004) Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305\u2013331","journal-title":"Recent Prog Horm Res"},{"key":"1502_CR20","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.ijo.0803025","volume":"29","author":"RB Ceddia","year":"2005","unstructured":"Ceddia RB (2005) Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int J Obes (Lond) 29:1175\u20131183","journal-title":"Int J Obes (Lond)"},{"key":"1502_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BJ20051578","volume":"393","author":"G Fruhbeck","year":"2006","unstructured":"Fruhbeck G (2006) Intracellular signalling pathways activated by leptin. Biochem J 393:7\u201320","journal-title":"Biochem J"},{"key":"1502_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cellbi.2003.12.003","volume":"28","author":"K Hegyi","year":"2004","unstructured":"Hegyi K, Fulop K, Kovacs K, Toth S, Falus A (2004) Leptin-induced signal transduction pathways. Cell Biol Int 28:159\u2013169","journal-title":"Cell Biol Int"},{"key":"1502_CR23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI200419511","volume":"113","author":"E Asilmaz","year":"2004","unstructured":"Asilmaz E, Cohen P, Miyazaki M et al (2004) Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest 113:414\u2013424","journal-title":"J Clin Invest"},{"key":"1502_CR24","doi-asserted-by":"crossref","first-page":"2455S","DOI":"10.1093\/jn\/134.9.2455S","volume":"134","author":"P Cohen","year":"2004","unstructured":"Cohen P, Friedman JM (2004) Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). J Nutr 134:2455S\u20132463S","journal-title":"J Nutr"},{"issue":"Suppl 2","key":"1502_CR25","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2337\/db06-S018","volume":"55","author":"RS Ahima","year":"2006","unstructured":"Ahima RS, Qi Y, Singhal NS, Jackson MB, Scherer PE (2006) Brain adipocytokine action and metabolic regulation. Diabetes 55(Suppl 2):S145\u2013S154","journal-title":"Diabetes"},{"key":"1502_CR26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/jc.2005-1220","volume":"91","author":"EA Oral","year":"2006","unstructured":"Oral EA, Javor ED, Ding L et al (2006) Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy. J Clin Endocrinol Metab 91:621\u2013628","journal-title":"J Clin Endocrinol Metab"},{"key":"1502_CR27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.20672","volume":"41","author":"ED Javor","year":"2005","unstructured":"Javor ED, Ghany MG, Cochran EK et al (2005) Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy. Hepatology 41:753\u2013760","journal-title":"Hepatology"},{"key":"1502_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.metabol.2004.08.021","volume":"54","author":"C Musso","year":"2005","unstructured":"Musso C, Cochran E, Javor E, Young J, Depaoli AM, Gorden P (2005) The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients. Metabolism 54:255\u2013263","journal-title":"Metabolism"},{"key":"1502_CR29","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1210\/jcem.87.7.8591","volume":"87","author":"EA Oral","year":"2002","unstructured":"Oral EA, Ruiz E, Andewelt A et al (2002) Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J Clin Endocrinol Metab 87:3110\u20133117","journal-title":"J Clin Endocrinol Metab"},{"key":"1502_CR30","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1210\/jc.2003-031952","volume":"89","author":"E Cochran","year":"2004","unstructured":"Cochran E, Young JR, Sebring N, DePaoli A, Oral EA, Gorden P (2004) Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson\u2013Mendenhall syndrome. J Clin Endocrinol Metab 89:1548\u20131554","journal-title":"J Clin Endocrinol Metab"},{"key":"1502_CR31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa040388","volume":"351","author":"CK Welt","year":"2004","unstructured":"Welt CK, Chan JL, Bullen J et al (2004) Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 351:987\u2013997","journal-title":"N Engl J Med"},{"key":"1502_CR32","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","volume":"341","author":"IS Farooqi","year":"1999","unstructured":"Farooqi IS, Jebb SA, Langmack G et al (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879\u2013884","journal-title":"N Engl J Med"},{"key":"1502_CR33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","volume":"110","author":"IS Farooqi","year":"2002","unstructured":"Farooqi IS, Matarese G, Lord GM et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093\u20131103","journal-title":"J Clin Invest"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1502-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-009-1502-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1502-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:47:14Z","timestamp":1558597634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-009-1502-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["1502"],"URL":"https:\/\/doi.org\/10.1007\/s00125-009-1502-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,2]]}}}